Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
Tardif JC, Grégoire J, L'Allier PL, Anderson TJ, Bertrand O, Reeves F, Title LM, Alfonso F, Schampaert E, Hassan A, McLain R, Pressler ML, Ibrahim R, Lespérance J, Blue J, Heinonen T, Rodés-Cabau J; Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators. Tardif JC, et al. Among authors: schampaert e. Circulation. 2004 Nov 23;110(21):3372-7. doi: 10.1161/01.CIR.0000147777.12010.EF. Epub 2004 Nov 8. Circulation. 2004. PMID: 15533865 Clinical Trial.
Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial.
Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Anderson TJ, Reeves F, Title LM, Schampaert E, LeMay M, Lespérance J, Scott R, Guertin MC, Brennan ML, Hazen SL, Bertrand OF; CART-2 Investigators. Tardif JC, et al. Among authors: schampaert e. Atherosclerosis. 2008 Mar;197(1):480-6. doi: 10.1016/j.atherosclerosis.2006.11.039. Epub 2007 Jan 9. Atherosclerosis. 2008. PMID: 17214993 Clinical Trial.
Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies.
Kouz R, Kouz S, Schampaert E, Rinfret S, Tardif JC, Nguyen M, Eisenberg M, Harvey R, Afilalo M, Lauzon C, Dery JP, Mansour S, Huynh T. Kouz R, et al. Among authors: schampaert e. Int J Cardiol. 2011 Dec 15;153(3):249-55. doi: 10.1016/j.ijcard.2010.08.019. Epub 2010 Oct 25. Int J Cardiol. 2011. PMID: 20971515
Strategies for multivessel revascularization in patients with diabetes.
Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators. Farkouh ME, et al. N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4. N Engl J Med. 2012. PMID: 23121323 Free article. Clinical Trial.
Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians.
Couture EL, Farand P, Nguyen M, Allard C, Wells GA, Mansour S, Rinfret S, Afilalo J, Eisenberg M, Montigny M, Kouz S, Afilalo M, Lauzon C, Dery JP, L'Allier P, Schampaert E, Tardif JC, Huynh T. Couture EL, et al. Among authors: schampaert e. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E441-E448. doi: 10.1002/ccd.27877. Epub 2018 Sep 30. Catheter Cardiovasc Interv. 2018. PMID: 30269415
Racial Disparities in Acute Coronary Syndrome Management Within a Universal Healthcare Context: Insights From the AMI-OPTIMA Trial.
d'Entremont MA, Wee CC, Nguyen M, Couture ÉL, Lemaire-Paquette S, Kouz S, Afilalo M, Rinfret S, Schampaert E, Mansour S, Montigny M, Eisenberg M, Lauzon C, Déry JP, L'Allier P, Tardif JC, Huynh T. d'Entremont MA, et al. Among authors: schampaert e. CJC Open. 2021 Jul 24;3(12 Suppl):S28-S35. doi: 10.1016/j.cjco.2021.07.006. eCollection 2021 Dec. CJC Open. 2021. PMID: 34993431 Free PMC article.
Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial.
Généreux P, Chernin G, Assali AR, Peruga JZ, Robinson SD, Schampaert E, Bagur R, Mansour S, Rodés-Cabau J, McEntegart M, Gerber R, L'Allier P, de Silva R, Daneault B, Aggarwal SK, Džavík V, Ozan MO, Ben-Yehuda O, Maehara A, Stone GW, Jonas M. Généreux P, et al. Among authors: schampaert e. Am Heart J. 2022 Jul;249:45-56. doi: 10.1016/j.ahj.2022.03.004. Epub 2022 Mar 17. Am Heart J. 2022. PMID: 35305955 Clinical Trial.
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial.
Jolicoeur EM, Dendukuri N, Belisle P, Range G, Souteyrand G, Bouisset F, Zemour G, Delarche N, Harbaoui B, Schampaert E, Kouz S, Cayla G, Roubille F, Boueri Z, Mansour S, Marcaggi X, Tardif JC, McGillion M, Tanguay JF, Brophy J, Yu CW, Berry C, Carrick D, Høfsten DE, Engstrøm T, Kober L, Kelbæk H, Belle L. Jolicoeur EM, et al. Among authors: schampaert e. Can J Cardiol. 2020 Nov;36(11):1805-1814. doi: 10.1016/j.cjca.2020.01.019. Epub 2020 Jan 25. Can J Cardiol. 2020. PMID: 32798463 Review.
Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry.
El-Rayes M, Schampaert E, Tardif JC, Eisenberg MJ, Afilalo M, Kouz S, Lauzon C, Harvey R, Nguyen M, Kouz R, Dery JP, Mansour S, Van Kieu AM, Rinfret S, Huynh T. El-Rayes M, et al. Among authors: schampaert e. Can J Cardiol. 2010 Oct;26(8):431-6. doi: 10.1016/s0828-282x(10)70441-4. Can J Cardiol. 2010. PMID: 20931096 Free PMC article. Clinical Trial.
86 results